Cleared Abbreviated

K133988 - TEMPUS PRO EXTENDED FEATURES

K133988 is an FDA 510(k) clearance for TEMPUS PRO EXTENDED FEATURES, manufactured by Remote Diagnostic Technologies , Ltd.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Abbreviated 510(k) pathway after a 141-day FDA review.

K133988 · Remote Diagnostic Technologies , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2014
Decision
141d
Days
Class 2
Risk

K133988 is an FDA 510(k) clearance for the TEMPUS PRO EXTENDED FEATURES. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Remote Diagnostic Technologies , Ltd. (Hampshire, GB). The FDA issued a Cleared decision on May 16, 2014 after a review of 141 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Remote Diagnostic Technologies , Ltd. devices

FDA 510(k) Submission Details - K133988

510(k) Number K133988 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 2013
Decision Date May 16, 2014
Days to Decision 141 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
16d slower than avg
Panel avg: 125d · This submission: 141d
Pathway characteristics
Standards-based clearance path.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 160
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K133988.
MASIMO ROOT MONITORING SYSTEM
K140188 · Masimo Corporation · Jun 2014
740 SELECT
K140430 · Cas Medical Systems, Inc. · Jun 2014
HANDHELD MONITOR
K131762 · Guangdong Biolight Meditech Co., Ltd. · Jun 2014
VITAL SYNC INFORMATICS MANAGER & VIRTUAL PATIENT MONITORING PLATFORM
K140339 · Covidien · Apr 2014
A SERIES AND Q SERIES PATIENT MONITORS
K131898 · Guangdong Biolight Meditech Co., Ltd. · Feb 2014
MONITORING STATION, CONNEX(R) CENTRAL STATION (CS)
K132807 · Welch Allyn, Inc. · Jan 2014